Registration No.
Product Name
Company Name
Submit Date
Registration Status
Y20209990026
Lamivudine
Venture Pharmaceutical (Xiamen) Co., Ltd
-
A
Y20209990025
Metronidazole
Guangxi Jinxing industrial Co., Ltd
-
A
Y20209990024
Meclofenoxate Hydrochloride
Shandong Yijian Pharmaceutical Co., Ltd
-
A
Y20209990023
Sodium Ferulate
Shandong Yijian Pharmaceutical Co., Ltd
-
A
Y20209990022
Tiopronin
Shandong Yijian Pharmaceutical Co., Ltd
-
A
Y20209990021
Telmisartan
Shandong Yijian Pharmaceutical Co., Ltd
-
A
Y20209990020
Carbocysteine
Changchun Dazheng Pharmaceutical Technology Co., Ltd
-
A
Y20209990019
Tolbutamide
Guangzhou Hanfang Pharmaceutical Co., Ltd
-
A
Y20209990017
Dexrazoxane
Nanjing Hairun Pharmaceutical Co., Ltd
-
A
Y20209990016
Sulfadiazine
Foshan Nanhai Beisha Pharmaceutical Co., Ltd
-
A
Y20209990018
Telmisartan
Zhuhai Rundu Pharmaceutical Co., Ltd
-
A
Y20209990014
Recombinant Human Insulin
Novo Nordisk A/S; Novo Nordisk A/S; Novo Nordisk (China) Pharmaceutical Co., Ltd
-
A
Y20209990013
Insulin Aspart
Novo Nordisk A/S; Novo Nordisk A/S; Novo Nordisk (China) Pharmaceutical Co., Ltd
-
A
Y20209990012
Insulin Detemir
Novo Nordisk A/S; Novo Nordisk A/S; Novo Nordisk (China) Pharmaceutical Co., Ltd
-
A
Y20209990011
Recombinant Human Insulin
BIOTON S.A.; BIOTON S.A.; Scigenltd (Beijing) Biotechnology Co., Ltd
-
A
Y20209990010
Recombinant Insulin Glargine
Gan & Lee Pharmaceutical Co., Ltd
-
A
Y20209990009
Insulin Glargine Solution
Zhuhai United Laboratories Co., Ltd
-
A
Y20209990008
Recombinant Lispro Insulin
Gan & Lee Pharmaceutical Co., Ltd
-
A
Y20209990007
Insulin
Nanjing Xinbai Pharmaceutical Co., Ltd
-
A
Y20209990006
Recombinant Human Insulin
Jiangsu Wanbang Biochemical Medicine Co., Ltd
-
A
Database updated on Sep. 1, 2021
